ESR1 and breast cancer: Here, to determine whether HDAC9 also modulates ERα signaling in breast cancer cells, a luciferase reporter assays was used to test the activity of a 4‐kb fragment of the ERα promoter in MCF7 breast cancer cells transfected or not with a plasmid that expresses HDAC9FL.